CEP-1, Cit-Fibβ36–52, Cit-Fil307–324, Cit-His321–44, Cit-TNC1, Cit-TNC5, Cit-Vim2–17 and Cit-Vim60–75 antibodies were significantly more prevalent in progressors, as compared with non-progressors to arthritis (Supplementary Table S3, available at Rheumatology online). The gene discussed is VIM2P; the disease is arthritic joint disease.